References
- Breems DA, Van Putten WL, De Greef GE, . Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008;26:4791–4797.
- Medeiros BC, Othus M, Fang M, . Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood 2010;116:2224–2228.
- Perrot A, Luquet I, Pigneux A, . Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood 2011;118:679–685.
- Patnaik MM, Hanson CA, Hodnefield JM, . Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia 2011;25:266–270.
- Vaidya R, Caramazza D, Begna KH, . Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival. Blood 2011;117:5612–5615.
- Grimwade D, Hills RK, Moorman AV, . Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365.
- Seifert H, Mohr B, Thiede C, . The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia 2009;23:656–663.
- Tang YC, Williams BR, Siegel JJ, . Identification of aneuploidy-selective antiproliferation compounds. Cell 2011;144:499–512.
- Bowen D, Groves MJ, Burnett AK, . TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia 2009;23:203–206.
- Habermann JK, Brucker CA, Freitag-Wolf S, . Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma. Mod Pathol 2011;24:542–555.
- Jasek M, Gondek LP, Bejanyan N, . TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. Leukemia 2010;24:216–219.
- Nahi H, Selivanova G, Lehmann S, . Mutated and non-mutated TP53 as targets in the treatment of leukaemia. Br J Haematol 2008;141:445–453.
- Lambert JM, Gorzov P, Veprintsev DB, . PRIMA-1 reactivates mutant p53 by covalent binding to the core domain. Cancer Cell 2009;15:376–388.
- Nahi H, Merup M, Lehmann S, . PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. Br J Haematol 2006;132:230–236.
- Lambert JM, Moshfegh A, Hainaut P, . Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene 2010;29:1329–1338.